- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
SenzaGen AB (SENZA)
SenzaGen AB stock price live, this page displays ST SENZA stock exchange data. View the SENZA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the SenzaGen AB real time stock price chart below.
What Is the SenzaGen AB Stock Price Today?
The SenzaGen AB stock price today is 4.47.
What Is the Stock Symbol for SenzaGen AB?
The stock symbol for SenzaGen AB is "SENZA."
What Stock Exchange Does SenzaGen AB Trade On?
SenzaGen AB is listed and trades on the Stockholm stock exchange.
Is SenzaGen AB a Good Stock to Buy?
Determining whether SenzaGen AB, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SENZA quote. (ISIN: SE0010219626)
What Is the SenzaGen AB Stock Price Today?
The SenzaGen AB stock price today is 4.47.
What Is the Stock Symbol for SenzaGen AB?
The stock symbol for SenzaGen AB is "SENZA."
What Stock Exchange Does SenzaGen AB Trade On?
SenzaGen AB is listed and trades on the Stockholm stock exchange.
Is SenzaGen AB a Good Stock to Buy?
Determining whether SenzaGen AB, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SENZA quote. (ISIN: SE0010219626)
Stockholm
Currency in SEK
4.47
-0.41(-8.40%)
Closed·
Fair Value
An estimate of a SenzaGen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.40
4.70
52 wk Range
4.21
6.70
SENZA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a SenzaGen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.404.70
52 wk Range
4.216.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SENZA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a SenzaGen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
SenzaGen AB Earnings Call Summary for Q3/2025
- Sensagen reported Q3 2025 revenue of 15.2M SEK, an 18% YoY growth, achieving EBITDA break-even, though stock fell 7.69% in pre-market trading
- ToxHub sales tripled to represent 9% of group sales, while the company expanded its customer base with 10 new Guard customers
- Despite strong 66% gross margin and 29.3M SEK cash position, market reaction was negative, with stock trading near its 52-week low
- CEO Peter Nahlstedt highlighted Sensagen's evolution 'from industry challenger to established player' in animal-free testing
- Forward guidance focuses on scaling business efficiency, investing in medical devices and Aura platform, with potential OECD method approval by 2027
Last Updated: 05/11/2025, 10:52
Read Full TranscriptEarnings
Latest Release
Nov 06, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare SENZA to Peers and Sector
Metrics to compare | SENZA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSENZAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −19.9x | 29.6x | −0.2x | |
PEG Ratio | −1.66 | 2.72 | 0.00 | |
Price/Book | 1.6x | 6.8x | 2.6x | |
Price / LTM Sales | 2.3x | 3.5x | 2.8x | |
Upside (Analyst Target) | - | 0.9% | 65.0% | |
Fair Value Upside | Unlock | −6.3% | 9.6% | Unlock |
SenzaGen AB (publ) provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also provides biological evaluation, in vitro biocompatibility testing, cytotoxicity, irritation, and skin sensitization medical device services; advisory services for medical devices; and substance based medical devices. In addition, the company offers regulatory toxicity testing services, including skin corrosion, skin irritation, skin sensitization, and skin absorption; and eye irritation, phototoxicity, and cytotoxicity testing services and advisory services to pharma, medial devices, cosmetics, an chemical industries. Further, it provides SenzaGen, a test portfolio to assess toxicity of chemicals, cosmetics, medical devices, drug candidates, and nutrition/food additives. The company offers services through license partners and distributors. It has a collaboration agreement with the Research Institute for Fragrance Materials to develop tests for photosensitization. SenzaGen AB (publ) was incorporated in 2010 and is headquartered in Lund, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the SenzaGen (SENZA) Stock Price Today?
The SenzaGen stock price today is 4.47 SEK.
What Stock Exchange Does SenzaGen Trade On?
SenzaGen is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for SenzaGen?
The stock symbol for SenzaGen is "SENZA."
What Is the SenzaGen Market Cap?
As of today, SenzaGen market cap is 145.31M SEK.
What Is SenzaGen's Earnings Per Share (TTM)?
The SenzaGen EPS (TTM) is -0.23.
From a Technical Analysis Perspective, Is SENZA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has SenzaGen Stock Split?
SenzaGen has split 1 times.
How Many Employees Does SenzaGen Have?
SenzaGen has 34 employees.
What is the current trading status of SenzaGen (SENZA)?
As of Nov 14, 2026, SenzaGen (SENZA) is trading at a price of 4.47 SEK, with a previous close of 4.47 SEK. The stock has fluctuated within a day range of 4.40 SEK to 4.70 SEK, while its 52-week range spans from 4.21 SEK to 6.70 SEK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.